(19)
(11) EP 4 161 530 A1

(12)

(43) Date of publication:
12.04.2023 Bulletin 2023/15

(21) Application number: 21822852.6

(22) Date of filing: 07.06.2021
(51) International Patent Classification (IPC): 
A61K 31/57(2006.01)
A61P 3/04(2006.01)
 A61P 21/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 21/06; A61P 3/04; A61K 31/58
(86) International application number:
PCT/US2021/036089
(87) International publication number:
WO 2021/252314 (16.12.2021 Gazette 2021/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.06.2020 US 202063035863 P

(71) Applicant: Eliem Therapeutics (UK) Ltd
Altrincham, Cheshire, WA14 2DT (GB)

(72) Inventors:
  • LEVIN, Andrew, D.
    Newton, MA 02458 (US)
  • FELDMAN, Danielle
    Boston, MA 02116 (US)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) METHODS OF TREATING FEMALE HEALTH CONDITIONS RELATED TO SEX HORMONES